Avanos Medical

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$171,700
$166,100
$173,300
$171,300
Gross Profit
95,600
94,800
97,400
95,500
EBITDA
27,400
18,800
33,700
13,100
EBIT
16,100
7,400
22,200
2,100
Net Income
1,800
-900
10,500
-3,700
Net Change In Cash
171,700
166,100
173,300
171,300
Free Cash Flow
21,900
-12,099
6,800
25,200
Cash
92,200
75,800
87,700
107,100
Basic Shares
46,300
46,200
46,600
46,800

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$673,300
$820,000
$744,600
$714,800
Gross Profit
382,700
450,000
364,300
373,300
EBITDA
98,500
122,900
47,400
-2,000
EBIT
55,000
81,800
9,100
-44,900
Net Income
-61,800
50,500
6,300
-27,200
Net Change In Cash
673,300
820,000
744,600
714,800
Cost of Revenue
12,200
11,000
-96,700
Free Cash Flow
14,600
71,600
66,300
-22,700
Cash
87,700
127,700
118,500
111,500
Basic Shares
46,600
47,300
48,600
47,800

Earnings Calls

Quarter EPS
2024-06-30
$0.29
2024-03-31
$0.19
2023-12-31
$0.32
2023-09-30
$0.42